Obesity
9 Results found
Highlight of the month
Supporting weight management following GLP-1 de-prescription
One challenge that arises after the completion of any weight loss therapy is weight regain. OPTIFAST VLCD products can be beneficial to help individuals maintain nutritional balance and reduce overall caloric intake to support continued weight management.
See more
Would your patients on GLP-1 RAs benefit from nutrition support? OPTIFAST VLCD products can help meet nutritional requirements when appetite is affected by GLP-1 RA therapy.
The OPTIFAST Diabetes Management Guidelines have been developed to assist healthcare professionals manage patients with diabetes and excess weight who may be at greater health risk.
Lifestyle interventions are an important component of any pharmacological and surgical treatment. One such lifestyle intervention for weight management is Intermittent Fasting. These guidelines have been developed to provide guidance to healthcare professionals in the use of the OPTIFAST VLCD Program for Intermittent Fasting.
Summary of evidence focusing on the benefits of weight loss before bariatric surgery.
A protocol addressing the dietary management of overweight and obesity in female and male infertility, pregnancy, inter and postpartum, endometriosis and polycystic ovarian syndrome patients using the OPTIFAST VLCD Program. The protocol also provides information on what the the OPTIFAST VLCD Program is, how it has been developed and reviews clinical evidence for the conditions above.
A pre-operative protocol addressing obesity management pre & post-bariatric surgery and general surgical procedures to minimise surgical and post-surgical risks. The protocol highlights the fact that with the increase in bariatric surgeries being performed, there is an increased need for preoperative weight loss. This has been driven by the necessity to optimise the safety of surgery.
A protocol addressing treatment guidelines for those with co-morbidities: Heart Failure, Renal Disease, Pharmacological Interactions, Type 1 Diabetes, Type 2 Diabetes, Pregnancy & IVF (please see OPTIFAST FERTILITY PROTOCOL for more detailed information), Hypertension & Hepatic Disease (incl Gallstones).
The OPTIFAST VLCD Clinical Treatment Protocol is a step-by-step guide on how to recommend the OPTIFAST VLCD Program to patients. If you are new to the OPTIFAST Program, we recommend reading this protocol first, followed by our supporting protocols (Management of complex cases, Preoperative, Fertility protocols). This protocol is suited to general practitioners, specialists, dietitians, pharmacists, surgeons, diabetes educators, exercise physiologists, researchers and specialist practice nurses.